|
Funding Opportunity Announcement Module (FOAM)
|
Resource Development
|
ACF, ACL, AHRQ, CDC, CMS, FDA
|
CIT, CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/All of Us, OD/OER
|
The Funding Opportunity Announcement Module (FOAM) allows National Institutes of Health (NIH) Institutes and Centers and Department of Health and Human Services (HHS) Operating Divisions to develop content for and perform the needed approvals to publish funding opportunity announcements. The system has a flexible configuration to meet all of the needs for HHS Operating Divisions. In addition FOAM serves as a Federal Shared Service in collaboration with Grant Solutions supporting other agencies including Department of the Interior, Department of Housing and Urban Development, and Department of Homeland Security. FOAM achieves economies of scale by preventing the need for individual agencies to develop duplicate systems at a cost much greater than that of developing a unified system.
|
|
FY 22 Ending the HIV Epidemic in the US Funding Opportunity Announcement
|
Research Initiative
|
CDC, HRSA
|
NIAID, NIDA, NIMH
|
Three NIH EHE RFAs supports locally defined and culturally sensitive research projects that address the four key pillars of the EHE initiative (Diagnose, Treat, Prevent, and Respond). Specifically the NIH supports investigators in one of the 57 priority jurisdictions to work with implementing partners to develop and test locally defined and culturally sensitive solutions that align with jurisdictional EHE plans. CDC and HRSA provided key support in the development of the research topics.
|
|
G7 Working Group on the Security and Integrity of the Global Research Ecosystem
|
Committee, Work group, Advisory group, or Task Force
|
Not Reported
|
OD/OER
|
Representatives from the US Department of State, NSF, and NIH engage in discussions with research integrity and research security government representatives from the G7. The purpose of this engagement is to develop a whitepaper and resources on G7 Common Values and Principles on Research Security and Research Integrity.
|
|
Gastrointestinal Acute Radiation Syndrome Workshop Planning Group
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIAID
|
The objectives of this in-person workshop, to be conducted in collaboration with the US Food and Drug Administration (FDA) and Biomedical Advanced Research and Development Authority (BARDA), are to explore aspects of radiation-induced gastrointestinal injury that are important to understand in order to move potential medical countermeasures (MCMs) for the syndrome forward in the drug development and licensure pathway. Subject matter experts and government staff involved in radiation MCM development will be involved in the presentations and discussions, and plan to publish a meeting report in an open-source peer-review journal article.
|
|
Gender-Based Violence National Plan Implementation Workgroup
|
Committee, Work group, Advisory group, or Task Force
|
Not Reported
|
NICHD
|
Through this National Plan to End Gender-Based Violence (National Plan), the Biden-Harris Administration is advancing a comprehensive, government-wide approach to preventing and addressing GBV in the United States. The National Plan identifies seven strategic pillars undergirding this approach: 1) Prevention; 2) Support, Healing, Safety, and Well-Being; 3) Economic Security and Housing Stability; 4) Online Safety; 5) Legal and Justice Systems; 6) Emergency Preparedness and Crisis Response; and 7) Research and Data. Building upon existing federal initiatives, the National Plan provides an important framework for strengthening ongoing federal action and interagency collaboration, and for informing new research, policy development, program planning, service delivery, and other efforts across each of these core issue areas. It is guided by the lessons learned and progress made as the result of tireless and courageous leadership from GBV survivors, advocates, researchers, and policymakers, as well as other dedicated professionals and community members who lead prevention and response efforts.
|
|
Genetic Epidemiology of Diabetes and Obesity
|
Research Initiative
|
IHS
|
NIDDK
|
Genetic Epidemiology of Diabetes and Obesity
|
|
Genetic Epidemiology of Diabetic Complications
|
Research Initiative
|
IHS
|
NIDDK
|
Genetic Epidemiology of Diabetic Complications
|
|
Genetic Studies in the National Birth Defects Prevention Study (NBDPS)
|
Research Initiative
|
CDC
|
NHGRI
|
This study is a collaboration between The Centers for Disease Control and Prevention (CDC) and the National Human Genome Research Institute (NHGRI) to carry out DNA sequencing and genotyping on samples collected as part of the National Birth Defects Prevention Study.
|
|
Genital Herpes Workshop
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NIAID
|
This workshop was co-sponsored by NIAID and CDC to review the status of research, product development, and education on genital herpes.
|
|
Genitourinary Cancers Steering Committee (GUSC) Clinical Trials Planning Meeting on ‘Defining the next generation of clinical trials with combination therapies in non-muscle invasive bladder cancer’
|
Meeting/ Workshop
|
FDA
|
NCI
|
The purpose of this meeting was to accelerate further advances in clinical trials for patients with high-risk non-muscle invasive bladder cancer (NMIBC). The meeting focused on the evaluation of strategies incorporating intravesical therapy, systemic therapy, trimodal therapy (incorporating radiation therapy), and combination therapies toward a goal of improving bladder preservation rates and survival outcomes for patients with high risk including BCG-unresponsive NMIBC.
|